RT Journal Article
SR Electronic
T1 Development of a parent-reported screening tool for avoidant/restrictive food intake disorder (ARFID): Initial validation and prevalence in 4-7-year-old Japanese children
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.11.21254533
DO 10.1101/2021.05.11.21254533
A1 Dinkler, Lisa
A1 Yasumitsu-Lovell, Kahoko
A1 Eitoku, Masamitsu
A1 Fujieda, Mikiya
A1 Suganuma, Narufumi
A1 Hatakenaka, Yuhei
A1 Hadjikhani, Nouchine
A1 Bryant-Waugh, Rachel
A1 Råstam, Maria
A1 Gillberg, Christopher
YR 2021
UL http://medrxiv.org/content/early/2021/09/24/2021.05.11.21254533.abstract
AB The prevalence of avoidant/restrictive food intake disorder (ARFID) in the general child population is still largely unknown and validated screening instruments are lacking. The aims of this study were to investigate the prevalence of children screening positive for ARFID in a Japanese birth cohort using a newly developed parent-reported screening tool, to estimate the prevalence of children with ARFID experiencing physical versus psychosocial consequences of their eating pattern, and to provide preliminary evidence for the validity of the new screening tool. Data were collected from 3,728 4-7-year-old children born in Kochi prefecture (response rate was 56.5%), Japan, between 2011 and 2014; a sub-sample of the Japan Environment and Children’s Study (JECS). Parents completed a questionnaire including the ARFID screener and several other measures to assess convergent validity. The point prevalence of children screening positive for ARFID was 1.3%; half of them met criteria for ARFID based on psychosocial impairment alone, while the other half met diagnostic criteria relating to physical impairment (and additional psychosocial impairment in many cases). Sensory sensitivity to food characteristics (63%) and/or lack of interest in eating (51%) were the most prevalent drivers of food avoidance. Children screening positive for ARFID were lighter in weight and shorter in height, they showed more problem behaviors related to mealtimes and nutritional intake, and they were more often selective eaters and more responsive to satiety, providing preliminary support for the validity of the new screening tool. This is the largest screening study to date of ARFID in children up to 7 years. Future studies should examine the diagnostic validity of the new ARFID screener using clinically ascertained cases. Further research on ARFID prevalence in the general population is needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Research Council (M.R., 2018-02544; C.G., 538-2013-8864), Torsten Soederbergs Foundation (C.G., M151/14), AnnMari and Per Ahlqvist Foundation (C.G., 2018), Japan Society for the Promotion of Science (M.F., 18KK0263), Scandinavia-Japan Sasakawa Foundation (L.D., 2016), Samariten Foundation (L.D., 2017-0283), Wilhelm and Martina Lundgrens Foundation (L.D., 2017-1738), Petter Silfverskioelds Memorial Foundation (L.D., 2017-093 & 2018-142), Professor Bror Gadelius Memorial Foundation (L.D., 2019 & 2020), and Solstickan Foundation (L.D., 2020). The Japan Environment and Childrens Study was funded by the Ministry of the Environment, Japan. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee at Kochi Medical School (ERB-102925 and ERB-104083).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are unsuitable for public deposition due to ethical restrictions and legal framework of Japan. It is prohibited by the Act on the Protection of Personal Information (Act No. 57 of 30 May 2003, amendment on 9 September 2015) to publicly deposit the data containing personal information. Ethical Guidelines for Medical and Health Research Involving Human Subjects enforced by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare also restricts the open sharing of the epidemiologic data. All inquiries about access to data should be sent to: jecs-en@nies.go.jp. The person responsible for handling enquiries sent to this e-mail address is Dr Shoji F. Nakayama, JECS Programme Office, National Institute for Environmental Studies.ARFIDAvoidant/Restrictive Food Intake DisorderARFID-BSARFID-Brief ScreenerBPFASBehavioral Pediatric Feeding Assessment ScaleCEBQChild Eating Behavior QuestionnaireEDY-QEating Disorder in Youth-QuestionnaireJECSJapan Environment and Children’s Study